{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T09:02:32Z","timestamp":1793696552325,"version":"4.5.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,15]],"date-time":"2015-02-15T00:00:00Z","timestamp":1423958400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12964-014-0081-7","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T09:28:00Z","timestamp":1424165280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction"],"prefix":"10.1186","volume":"13","author":[{"given":"Dirk","family":"Fahrenkamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard Schmitz-Van","family":"de Leur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"K\u00fcster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Chatain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"M\u00fcller-Newen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,15]]},"reference":[{"key":"81_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002;3:651\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"81_CR2","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.2741\/2274","volume":"12","author":"KD Bunting","year":"2007","unstructured":"Bunting KD. STAT5 signaling in normal and pathologic hematopoiesis. Front Biosci. 2007;12:2807\u201320.","journal-title":"Front Biosci"},{"key":"81_CR3","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/onc.2012.347","volume":"32","author":"W Vainchenker","year":"2013","unstructured":"Vainchenker W, Constantinescu SN. JAK\/STAT signaling in hematological malignancies. Oncogene. 2013;32:2601\u201313.","journal-title":"Oncogene"},{"key":"81_CR4","doi-asserted-by":"publisher","first-page":"8017","DOI":"10.1038\/sj.onc.1208159","volume":"23","author":"CM Silva","year":"2004","unstructured":"Silva CM. Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis. Oncogene. 2004;23:8017\u201323.","journal-title":"Oncogene"},{"key":"81_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1101\/gad.11.2.179","volume":"11","author":"X Liu","year":"1997","unstructured":"Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L. Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev. 1997;11:179\u201386.","journal-title":"Genes Dev"},{"key":"81_CR6","doi-asserted-by":"publisher","first-page":"7239","DOI":"10.1073\/pnas.94.14.7239","volume":"94","author":"GB Udy","year":"1997","unstructured":"Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, et al. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Natl Acad Sci U S A. 1997;94:7239\u201344.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"81_CR7","doi-asserted-by":"publisher","first-page":"4898","DOI":"10.1182\/blood-2005-09-3596","volume":"107","author":"A Hoelbl","year":"2006","unstructured":"Hoelbl A, Kovacic B, Kerenyi MA, Simma O, Warsch W, Cui Y, et al. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood. 2006;107:4898\u2013906.","journal-title":"Blood"},{"key":"81_CR8","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1101\/gad.14.2.232","volume":"14","author":"M Kieslinger","year":"2000","unstructured":"Kieslinger M, Woldman I, Moriggl R, Hofmann J, Marine JC, Ihle JN, et al. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation. Genes Dev. 2000;14:232\u201344.","journal-title":"Genes Dev"},{"key":"81_CR9","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343\u201356.","journal-title":"Blood"},{"key":"81_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nchembio.775","volume":"8","author":"O Hantschel","year":"2012","unstructured":"Hantschel O, Warsch W, Eckelhart E, Kaupe I, Grebien F, Wagner K-U, et al. BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia. Nat Chem Biol. 2012;8:285\u201393.","journal-title":"Nat Chem Biol"},{"key":"81_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/emmm.201000062","volume":"2","author":"A Hoelbl","year":"2010","unstructured":"Hoelbl A, Schuster C, Kovacic B, Zhu B, Wickre M, Hoelzl M, et al. Stat5 is indispensable for the maintenance of bcr\/abl-positive leukaemia. EMBO Mol Med. 2010;2:98\u2013110.","journal-title":"EMBO Mol Med"},{"key":"81_CR12","doi-asserted-by":"publisher","first-page":"3550","DOI":"10.1182\/blood-2011-12-397554","volume":"119","author":"C Walz","year":"2012","unstructured":"Walz C, Ahmed W, Lazarides K, Betancur M, Patel N, Hennighausen L, et al. Essential role for Stat5a\/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2 (V617F) in mice. Blood. 2012;119:3550\u201360.","journal-title":"Blood"},{"key":"81_CR13","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1182\/blood-2006-01-029918","volume":"109","author":"N Harir","year":"2007","unstructured":"Harir N, Pecquet C, Kerenyi M, Sonneck K, Kovacic B, Nyga R, et al. Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias. Blood. 2007;109:1678\u201386.","journal-title":"Blood"},{"key":"81_CR14","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1182\/blood.V101.2.690","volume":"101","author":"NJ Donato","year":"2003","unstructured":"Donato NJ, Wu JY, Stapley J, Gallick G, Lin H, Arlinghaus R, et al. BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571. Blood. 2003;101:690\u20138.","journal-title":"Blood"},{"key":"81_CR15","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1158\/1535-7163.MCT-09-0168","volume":"8","author":"S Grosso","year":"2009","unstructured":"Grosso S, Puissant A, Dufies M, Colosetti P, Jacquel A, Lebrigand K, et al. Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors. Mol Cancer Ther. 2009;8:1924\u201333.","journal-title":"Mol Cancer Ther"},{"key":"81_CR16","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1038\/onc.2008.330","volume":"27","author":"T Pene-Dumitrescu","year":"2008","unstructured":"Pene-Dumitrescu T, Peterson LF, Donato NJ, Smithgall TE. An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259. Oncogene. 2008;27:7055\u201369.","journal-title":"Oncogene"},{"key":"81_CR17","first-page":"3589","volume":"56","author":"S Danhauser-Riedl","year":"1996","unstructured":"Danhauser-Riedl S, Warmuth M, Druker BJ, Emmerich B, Hallek M. Activation of Src kinases p53\/56lyn and p59hck by p210bcr\/abl in myeloid cells. Cancer Res. 1996;56:3589\u201396.","journal-title":"Cancer Res"},{"key":"81_CR18","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1093\/emboj\/cdf562","volume":"21","author":"A Klejman","year":"2002","unstructured":"Klejman A, Schreiner SJ, Nieborowska-Skorska M, Slupianek A, Wilson M, Smithgall TE, et al. The Src family kinase Hck couples BCR\/ABL to STAT5 activation in myeloid leukemia cells. EMBO J. 2002;21:5766\u201374.","journal-title":"EMBO J"},{"key":"81_CR19","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1038\/onc.2012.369","volume":"32","author":"N Chatain","year":"2013","unstructured":"Chatain N, Ziegler P, Fahrenkamp D, Jost E, Moriggl R, Schmitz-Van de Leur H, et al. Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells. Oncogene. 2013;32:3587\u201397.","journal-title":"Oncogene"},{"issue":"Pt 18","key":"81_CR20","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1242\/jcs.03482","volume":"120","author":"A Herrmann","year":"2007","unstructured":"Herrmann A, Vogt M, M\u00f6nnigmann M, Clahsen T, Sommer U, Haan S, et al. Nucleocytoplasmic shuttling of persistently activated STAT3. J Cell Sci. 2007;120(Pt 18):3249\u201361.","journal-title":"J Cell Sci"},{"key":"81_CR21","doi-asserted-by":"publisher","first-page":"6643","DOI":"10.1038\/sj.onc.1204807","volume":"20","author":"Y Okutani","year":"2001","unstructured":"Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, et al. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Oncogene. 2001;20:6643\u201350.","journal-title":"Oncogene"},{"key":"81_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0092-8674(87)90756-2","volume":"49","author":"TE Kmiecik","year":"1987","unstructured":"Kmiecik TE, Shalloway D. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell. 1987;49:65\u201373.","journal-title":"Cell"},{"key":"81_CR23","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1097-2765(00)80356-1","volume":"3","author":"W Xu","year":"1999","unstructured":"Xu W, Doshi A, Lei M, Eck MJ, Harrison SC. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell. 1999;3:629\u201338.","journal-title":"Mol Cell"},{"key":"81_CR24","doi-asserted-by":"publisher","first-page":"D261","DOI":"10.1093\/nar\/gkr1122","volume":"40","author":"PV Hornbeck","year":"2012","unstructured":"Hornbeck PV, Kornhauser JM, Tkachev S, Zhang B, Skrzypek E, Murray B, et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 2012;40:D261\u201370.","journal-title":"Nucleic Acids Res"},{"key":"81_CR25","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/0264-6021:3450417","volume":"3","author":"S Haan","year":"2000","unstructured":"Haan S, Kortylewski M, Behrmann I, M\u00fcller-Esterl W, Heinrich PC, Schaper F. Cytoplasmic STAT proteins associate prior to activation. Biochem J. 2000;3:417\u201321.","journal-title":"Biochem J"},{"key":"81_CR26","doi-asserted-by":"publisher","first-page":"34133","DOI":"10.1074\/jbc.M304531200","volume":"278","author":"J Braunstein","year":"2003","unstructured":"Braunstein J, Brutsaert S, Olson R, Schindler C. STATs dimerize in the absence of phosphorylation. J Biol Chem. 2003;278:34133\u201340.","journal-title":"J Biol Chem"},{"key":"81_CR27","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1242\/jcs.137422","volume":"127","author":"T Domoszlai","year":"2014","unstructured":"Domoszlai T, Martincuks A, Fahrenkamp D, Schmitz-Van de Leur H, K\u00fcster A, M\u00fcller-Newen G. Consequences of the disease-related L78R mutation for dimerization and activity of STAT3. J Cell Sci. 2014;127:1899\u2013910.","journal-title":"J Cell Sci"},{"key":"81_CR28","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/MCB.18.7.3871","volume":"18","author":"M Onishi","year":"1998","unstructured":"Onishi M, Nosaka T, Misawa K, Mui AL, Gorman D, McMahon M, et al. Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol. 1998;18:3871\u20139.","journal-title":"Mol Cell Biol"},{"key":"81_CR29","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","volume":"101","author":"M Benekli","year":"2003","unstructured":"Benekli M, Baer MR, Baumann H, Wetzler M. Signal transducer and activator of transcription proteins in leukemias. Blood. 2003;101:2940\u201354.","journal-title":"Blood"},{"key":"81_CR30","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.2353\/ajpath.2009.080953","volume":"175","author":"C Baumgartner","year":"2009","unstructured":"Baumgartner C, Cerny-Reiterer S, Sonneck K, Mayerhofer M, Gleixner KV, Fritz R, et al. Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V. Am J Pathol. 2009;175:2416\u201329.","journal-title":"Am J Pathol"},{"key":"81_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1006\/bbrc.2000.3803","volume":"278","author":"A Oda","year":"2000","unstructured":"Oda A, Wakao H, Fujihara M, Ozaki K, Komatsu N, Tanaka S, et al. Thrombopoietin and interleukin-2 induce association of CRK with STAT5. Biochem Biophys Res Commun. 2000;278:299\u2013305.","journal-title":"Biochem Biophys Res Commun"},{"key":"81_CR32","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/sj.onc.1203418","volume":"19","author":"SC Rosa Santos","year":"2000","unstructured":"Rosa Santos SC, Dumon S, Mayeux P, Gisselbrecht S, Gouilleux F. Cooperation between STAT5 and phosphatidylinositol 3-kinase in the IL-3-dependent survival of a bone marrow derived cell line. Oncogene. 2000;19:1164\u201372.","journal-title":"Oncogene"},{"key":"81_CR33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000049187","volume":"18","author":"JL Brockdorff","year":"2001","unstructured":"Brockdorff JL, Gu H, Mustelin T, Kaltoft K, Geisler C, R\u00f6pke C, et al. Gab2 is phosphorylated on tyrosine upon interleukin-2\/interleukin-15 stimulation in mycosis-fungoides-derived tumor T cells and associates inducibly with SHP-2 and Stat5a. Exp Clin Immunogenet. 2001;18:86\u201395.","journal-title":"Exp Clin Immunogenet"},{"key":"81_CR34","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/sj.onc.1204308","volume":"20","author":"SC Santos","year":"2001","unstructured":"Santos SC, Lacronique V, Bouchaert I, Monni R, Bernard O, Gisselbrecht S, et al. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase\/Akt dependent pathway. Oncogene. 2001;20:2080\u201390.","journal-title":"Oncogene"},{"key":"81_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1042\/BJ20041523","volume":"390","author":"R Nyga","year":"2005","unstructured":"Nyga R, Pecquet C, Harir N, Gu H, Dhennin-Duthille I, R\u00e9gnier A, et al. Activated STAT5 proteins induce activation of the PI 3-kinase\/Akt and Ras\/MAPK pathways via the Gab2 scaffolding adapter. Biochem J. 2005;390:359\u201366.","journal-title":"Biochem J"},{"key":"81_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jcp.21112","volume":"213","author":"R Poincloux","year":"2007","unstructured":"Poincloux R, Cougoule C, Daubon T, Maridonneau-Parini I, Le Cabec V. Tyrosine-phosphorylated STAT5 accumulates on podosomes in Hck-transformed fibroblasts and chronic myeloid leukemia cells. J Cell Physiol. 2007;213:212\u201320.","journal-title":"J Cell Physiol"},{"key":"81_CR37","doi-asserted-by":"publisher","first-page":"22484","DOI":"10.1074\/jbc.274.32.22484","volume":"274","author":"AV Kazansky","year":"1999","unstructured":"Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM. Differential effects of prolactin and src\/abl kinases on the nuclear translocation of STAT5B and STAT5A. J Biol Chem. 1999;274:22484\u201392.","journal-title":"J Biol Chem"},{"key":"81_CR38","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1128\/MCB.18.5.2553","volume":"18","author":"JF Bromberg","year":"1998","unstructured":"Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE. Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol. 1998;18:2553\u20138.","journal-title":"Mol Cell Biol"},{"key":"81_CR39","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/MCB.18.5.2545","volume":"18","author":"J Turkson","year":"1998","unstructured":"Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol Cell Biol. 1998;18:2545\u201352.","journal-title":"Mol Cell Biol"},{"key":"81_CR40","first-page":"1","volume":"12","author":"AV Kazansky","year":"2001","unstructured":"Kazansky AV, Rosen JM. Signal transducers and activators of transcription 5B potentiates v-Src-mediated transformation of NIH-3T3 cells. Cell Growth Differ. 2001;12:1\u20137.","journal-title":"Cell Growth Differ"},{"key":"81_CR41","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1158\/0008-5472.CAN-12-3955","volume":"73","author":"L Casetti","year":"2013","unstructured":"Casetti L, Martin-Lanner\u00e9e S, Najjar I, Plo I, Aug\u00e9 S, Roy L, et al. Differential contributions of STAT5A and STAT5B to stress protection and tyrosine kinase inhibitor resistance of chronic myeloid leukemia stem\/progenitor cells. Cancer Res. 2013;73:2052\u20138.","journal-title":"Cancer Res"},{"key":"81_CR42","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/leu.2012.112","volume":"26","author":"E Cholez","year":"2012","unstructured":"Cholez E, Debuysscher V, Bourgeais J, Boudot C, Leprince J, Tron F, et al. Evidence for a protective role of the STAT5 transcription factor against oxidative stress in human leukemic pre-B cells. Leukemia. 2012;26:2390\u20137.","journal-title":"Leukemia"},{"key":"81_CR43","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.18632\/oncotarget.806","volume":"3","author":"W Warsch","year":"2012","unstructured":"Warsch W, Grundschober E, Berger A, Gille L, Cerny-Reiterer S, Tigan A, et al. STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia. Oncotarget. 2012;3:1669\u201387.","journal-title":"Oncotarget"},{"key":"81_CR44","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1038\/sj.onc.1209949","volume":"26","author":"C Pecquet","year":"2007","unstructured":"Pecquet C, Nyga R, Penard-Lacronique V, Smithgall TE, Murakami H, R\u00e9gnier A, et al. The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation. Oncogene. 2007;26:1577\u201385.","journal-title":"Oncogene"},{"key":"81_CR45","doi-asserted-by":"publisher","first-page":"18581","DOI":"10.1074\/jbc.C000126200","volume":"275","author":"JM Lionberger","year":"2000","unstructured":"Lionberger JM, Wilson MB, Smithgall TE. Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck. J Biol Chem. 2000;275:18581\u20135.","journal-title":"J Biol Chem"},{"key":"81_CR46","doi-asserted-by":"publisher","first-page":"17218","DOI":"10.1074\/jbc.M301578200","volume":"278","author":"EB Kabotyanski","year":"2003","unstructured":"Kabotyanski EB, Rosen JM. Signal transduction pathways regulated by prolactin and Src result in different conformations of activated Stat5b. J Biol Chem. 2003;278:17218\u201327.","journal-title":"J Biol Chem"},{"key":"81_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molcel.2011.12.026","volume":"45","author":"T Van Nguyen","year":"2012","unstructured":"Van Nguyen T, Angkasekwinai P, Dou H, Lin F, Lu L-S, Cheng J, et al. SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation. Mol Cell. 2012;45:210\u201321.","journal-title":"Mol Cell"},{"key":"81_CR48","doi-asserted-by":"publisher","first-page":"16520","DOI":"10.1074\/jbc.M210572200","volume":"278","author":"Y Chen","year":"2003","unstructured":"Chen Y, Wen R, Yang S, Schuman J, Zhang EE, Yi T, et al. Identification of Shp-2 as a Stat5A phosphatase. J Biol Chem. 2003;278:16520\u20137.","journal-title":"J Biol Chem"},{"key":"81_CR49","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.2353\/ajpath.2010.090399","volume":"177","author":"KJ Johnson","year":"2010","unstructured":"Johnson KJ, Peck AR, Liu C, Tran TH, Utama FE, Sjolund AB, et al. PTP1B suppresses prolactin activation of Stat5 in breast cancer cells. Am J Pathol. 2010;177:2971\u201383.","journal-title":"Am J Pathol"},{"key":"81_CR50","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1242\/jcs.072520","volume":"124","author":"M Vogt","year":"2011","unstructured":"Vogt M, Domoszlai T, Kleshchanok D, Lehmann S, Schmitt A, Poli V, et al. The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3. J Cell Sci. 2011;124:900\u20139.","journal-title":"J Cell Sci"},{"key":"81_CR51","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/bioinformatics\/btm404","volume":"23","author":"MA Larkin","year":"2007","unstructured":"Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947\u20138.","journal-title":"Bioinformatics"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-014-0081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12964-014-0081-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-014-0081-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-014-0081-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T22:13:19Z","timestamp":1651270399000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-014-0081-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,15]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["81"],"URL":"https:\/\/doi.org\/10.1186\/s12964-014-0081-7","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,15]]},"assertion":[{"value":"18 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"10"}}